Mermaid Medical Group® is pleased to announce that the Angel® Catheter has officially received CE marking, confirming compliance with the European Union’s health, safety, and environmental protection requirements.
Copenhagen, Denmark, April 2026
Angel® Catheter Receives CE Marking
Mermaid Medical Group® is pleased to announced that the Angel® Catheter has officially received CE marking, enabling its commercial availability across Europe.
This milestone marks an important step for Mermaid Medical, as the Angel® Catheter is manufactured by the company, supporting its strategic focus on delivering innovative interventional solutions. With CE marking in place, Mermaid Medical can now offer the Angel Catheter to healthcare professionals throughout Europe as part of its continued expansion.
About the Angel® Catheter
The Angel® Catheter is designed to help prevent pulmonary embolism by stopping dangerous blood clots from reaching the lungs in patients who cannot safely receive anticoagulant therapy.
Certain critically ill or injured patients are at high risk of developing blood clots early during hospitalization. In situations where blood‑thinning medication is contraindicated due to bleeding risk or recent or planned surgery, options can be limited. The Angel Catheter addresses this clinical challenge by offering protection during these high-risk periods.
The device is intended to support clinicians in managing patients during so‑called “unprotected windows,” where standard prophylactic options may not be suitable.
Leadership Perspective
“Receiving CE marking for the Angel® Catheter is a proud moment for Mermaid Medical and a reflection of the strong collaboration and commitment behind the scenes,” says Sebastian Jørgensen, Marketing Director at Mermaid Medical Group.
“The experience gained throughout this process not only strengthens this launch but also supports the continued evolution of our portfolio. We are excited to bring this innovation to ICUs across Europe, where it has the potential to support clinicians and make a real difference when critically ill patients need protection the most.”
Looking Ahead: European Launch and Collaboration
With CE marking secured, Mermaid Medical Group is preparing for a phased European launch of the Angel® Catheter. The company looks forward to continued collaboration with clinical partners across the region and is supporting the introduction with clinical education, product training, and targeted awareness initiatives.
For more information, to request a product demonstration, or to arrange a trial evaluation, please contact us.
Media Contact:
Anne Sandgaard
Mermaid Medical Group
+45 2194 8508
asa@mermaidmedical.com
Mermaid Medical continues to expand its global presence, marking a significant milestone with the opening of a new office in Switzerland, bringing its expertise and solutions closer to healthcare professionals in the region.
Mermaid Medical Group® expands its partnership with Front Line Medical Technologies Inc. to bring the COBRA-OS® device to Belgium, the Netherlands, and Luxembourg
Mermaid Medical Group® announces first microwave ablation of benign thyroid nodules in Sweden, performed by Dr. Artturi Petäjä using the MaxBlate® Microwave Ablation System.